Literature DB >> 12715083

Antinociceptive activity of Hypericum caprifoliatum and Hypericum polyanthemum (Guttiferae).

A F Viana1, A P Heckler, R Fenner, S M K Rates.   

Abstract

The aim of the present study was to assess the analgesic activity of the aerial parts of two Hypericum species native to Southern Brazil, H. caprifoliatum and H. polyanthemum. The antinociceptive effect of the H. polyanthemum cyclohexane extract (POL; 180 mg/kg) and of the H. caprifoliatum methanol (MET) and cyclohexane (CH) extracts (90 mg/kg) was evaluated in the hot-plate (ip and po) and writhing (po) tests using male Swiss CF1 mice weighing 22-27 g (N = 10 per group). All extracts displayed antinociceptive effects in the hot-plate test (MET ip = 48%, MET po = 39%, CH ip = 27%, CH po = 50%, POL ip = 74%, and POL po = 49% compared to control). Pretreatment with naloxone (2.5 mg/kg, sc) abolished the effects of CH and POL, and partially prevented the analgesia induced by MET administered by the ip (but not by the po) route. POL and CH (po) significantly reduced the number of writhes induced by acetic acid, while MET was ineffective in this regard. We conclude that the antinociceptive effects of the H. caprifoliatum (CH) and H. polyanthemum (POL) hexane extracts seem to be mediated by the opioid system. Moreover, the antinociceptive activity of the H. caprifoliatum MET extract seems to depend on at least two chemical substances (or groups of substances) with distinct pharmacokinetic profiles and mechanisms of action. Only the naloxone-insensitive component of MET activity showed good bioavailability following oral administration.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12715083     DOI: 10.1590/s0100-879x2003000500011

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  7 in total

1.  Antinociceptive activity of Hypericum grandifolium Choisy in mice.

Authors:  Celia Xiomara Bonkanka; Candelaria Del Carmen Sánchez-Mateo; Rosa María Rabanal
Journal:  J Nat Med       Date:  2010-10-16       Impact factor: 2.343

2.  The effect of Hypericum perforatum (St. John's Wort) on experimental colitis in rat.

Authors:  Turhan Dost; Hakan Ozkayran; Filiz Gokalp; Cigdem Yenisey; Mustafa Birincioglu
Journal:  Dig Dis Sci       Date:  2008-08-27       Impact factor: 3.199

3.  Pharmacologic Overview of Chlorogenic Acid and its Metabolites in Chronic Pain and Inflammation.

Authors:  Deniz Bagdas; Zulfiye Gul; Julie A Meade; Betul Cam; Nilufer Cinkilic; Mine Sibel Gurun
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

4.  Analgesic Effect of 5-(3,4-Dihydroxyphenyl)-3-hydroxy-1-(2-hydroxyphenyl)penta-2,4-dien-1-one in Experimental Animal Models of Nociception.

Authors:  Nadhirah Kamarudin; Nadia Hisamuddin; Hui Ming Ong; Ahmad Farhan Ahmad Azmi; Sze Wei Leong; Faridah Abas; Mohd Roslan Sulaiman; Wan Mastura Shaik Mossadeq
Journal:  Molecules       Date:  2018-08-21       Impact factor: 4.411

5.  Antinociceptive activities of a novel diarylpentanoid analogue, 2-benzoyl-6-(3-bromo-4-hydroxybenzylidene)cyclohexen-1-ol, and its possible mechanisms of action in mice.

Authors:  Hui Ming Ong; Ahmad Farhan Ahmad Azmi; Sze Wei Leong; Faridah Abas; Enoch Kumar Perimal; Ahmad Akira Omar Farouk; Daud Ahmad Israf; Mohd Roslan Sulaiman
Journal:  Sci Rep       Date:  2021-12-16       Impact factor: 4.996

6.  Antinociceptive Activity of Trichilia catigua Hydroalcoholic Extract: New Evidence on Its Dopaminergic Effects.

Authors:  Alice F Viana; Izaque S Maciel; Emerson M Motta; Paulo C Leal; Luiz Pianowski; Maria M Campos; João B Calixto
Journal:  Evid Based Complement Alternat Med       Date:  2011-04-14       Impact factor: 2.629

7.  Pharmacological basis for the use of Hypericum oblongifolium as a medicinal plant in the management of pain, inflammation and pyrexia.

Authors:  Naila Raziq; Muhammad Saeed; Muhammad Shahid; Naveed Muhammad; Haroon Khan; Farah Gul
Journal:  BMC Complement Altern Med       Date:  2016-02-01       Impact factor: 3.659

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.